Source / episode info

• **Episode:**599
• **Title:**DIP Ep 599: The Clutch Dementia Podcast (Step 1-3)
• **Published:**2025-05-05
• Source:Episode page

One-liner

This episode provides a comprehensive review of dementia, emphasizing that diagnosis requires ruling out reversible causes and distinguishing between various syndromes (AD, LBD, NPH), while treatment strategies must be tailored to the specific underlying pathology.

High-yield summary

• Cognitive Impairment vs. Dementia: Mild Cognitive Impairment (MCI) is characterized by memory issues but preserved Activities of Daily Living (ADLs); dementia requires impairment in ADLs and a low Mini-Mental State Exam (MMSE) score.
• Alzheimer's Disease (AD): First-line pharmacotherapy involves an acetylcholinesterase inhibitor (AChEI) (e.g., donepezil, galantamine, rivastigmine). Pathophysiology includes atrophy of the hippocampus and loss of cholinergic neurons in the nucleus basalis of Meynert.
• Normal Pressure Hydrocephalus (NPH): Triad of symptoms is gait disturbance ("waky"), urinary incontinence ("wet"), and cognitive decline ("wobbly"). Diagnosis is supported by a dramatic improvement in symptoms following lumbar puncture/shunting, and CSF opening pressure is typically normal.
• Dementia Mimics: Always rule out reversible causes first: B12 deficiency, hypothyroidism, drug toxicity (especially anti-cholinergics), subdural hematoma, delirium, and hepatic encephalopathy.
• Pharmacological Safety: Anti-cholinergic drugs (e.g., diphenhydramine, tricyclic antidepressants) are strongly contraindicated in patients with dementia due to risk of exacerbating confusion/delirium.

Learning objectives

• Differentiate between Mild Cognitive Impairment (MCI) and established dementia based on ADL status.
• Identify the first-line pharmacological agents for Alzheimer's disease and understand their mechanism of action.
• Recognize the classic clinical triad, diagnostic findings, and management steps for Normal Pressure Hydrocephalus (NPH).
• List critical drug classes contraindicated in patients with cognitive impairment (e.g., anti-cholinergics, antipsychotics).
• Differentiate between various dementia syndromes (AD, LBD, Vascular, NPH) based on unique clinical presentations and associated findings.

Board exam buzzwords